Ubisoft announced in 2015 a partnership with Amblyotech and McGill University for medical games designed to help treat Amblyopia, or lazy eye. Aside from development, Amblyotech and Ubisoft needed to submit the product to the Food and Drug Administration for approval, before it could be allowed on the market as a prescription treatment. It's now a step closer to becoming a reality.
Ubisoft’s device is called the Amblyopad. When purchased through a doctor’s prescription, it will come preloaded with games called Dig Rush and Monster Burner. The games capture data as they are played, and patients will be expected to play for around one hour a week for 4-6 weeks.
Before this new venture from Amblyotech and Ubisoft, the primary treatment for Amblyopia has been to put an eyepatch over the stronger eye to promote growth in the weaker one. This treatment is dominant, but seen as not ideal due to “discomfort and social stigmas.” Having a cool, unique gaming device could definitely turn that around.